Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Pharmacokinetic Analysis Of In Vivo Disposition Of Succinylated Proteins Targeted To Liver Nonparenchymal Cells Via Scavenger Receptors: Importance Of Molecular Size And Negative Charge Density For In Vivo Recognition By Receptors.

Y. Yamasaki, K. Sumimoto, M. Nishikawa, F. Yamashita, K. Yamaoka, M. Hashida, Y. Takakura
Published 2002 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
In vivo disposition characteristics of succinylated (Suc-) proteins were studied after intravenous injection in mice in relation to their molecular characteristics as negatively charged macromolecules. Recombinant superoxide dismutase (SOD; molecular mass, 32 kDa), bovine serum albumin (BSA; molecular mass, 67 kDa), and bovine IgG (molecular mass, 150 kDa) were used to produce succinylated derivatives with different degrees of modification. (111)In-labeled Suc-SODs were rapidly excreted into the urine with no significant hepatic uptake. In contrast, (111)In-Suc-BSA and Suc-IgG were significantly taken up by liver nonparenchymal cells via scavenger receptors (SRs) according to the degree of succinylation and the dose injected. Interestingly, highly succinylated BSAs exhibited significant accumulation in the kidney at higher doses when the hepatic uptake was saturated. Pharmacokinetic analysis demonstrated that the hepatic uptake of succinylated proteins depended on the molecular size and the estimated surface density of succinylated amino residues. Further analysis based on a physiological pharmacokinetic model, involving a saturable process with Michaelis-Menten kinetics, revealed that the surface density of negative charges was correlated with the affinity of larger succinylated proteins for the hepatic SRs. Thus, the present study has provided useful basic information for a therapeutic strategy and the molecular design of succinylated proteins for use as drug carriers and therapeutic agents per se for SR-mediated targeting in vivo.
This paper references
10.1002/jlb.67.5.683
Scavenger receptor‐mediated delivery of muramyl dipeptide activates antitumor efficacy of macrophages by enhanced secretion of tumor‐suppressive cytokines
S. Srividya (2000)
10.1002/(SICI)1521-4141(199902)29:02<512::AID-IMMU512>3.0.CO;2-Y
The macrophage scavenger receptor type A directs modified proteins to antigen presentation
A. Nicoletti (1999)
10.1248/BPB1978.4.879
A pharmacokinetic analysis program (multi) for microcomputer.
K. Yamaoka (1981)
10.1016/0003-2697(66)90275-2
Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.
A. Habeeb (1966)
10.1161/01.ATV.20.8.1860
Hepatic and extrahepatic scavenger receptors: function in relation to disease.
V. Terpstra (2000)
Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
Y. Yabe (1999)
10.1016/0378-5173(94)90231-3
Pharmacokinetics of succinylated proteins and dextran sulfate in mice : implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors
Takakura Yoshinobu (1994)
10.1023/A:1016084508097
Macromolecular Carrier Systems for Targeted Drug Delivery: Pharmacokinetic Considerations on Biodistribution
Y. Takakura (2004)
10.1007/0-306-46831-X_1
Mannose receptor and scavenger receptor: two macrophage pattern recognition receptors with diverse functions in tissue homeostasis and host defense.
S. Linehan (2000)
10.1152/AJPRENAL.1983.244.4.F436
Renal tubular uptake of protein: effect of molecular charge.
E. Christensen (1983)
10.1248/BPB1978.6.595
A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers.
K. Yamaoka (1983)
A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides.
Y. Arano (1994)
Disruption of T cell tolerance by directing a self antigen to macrophage-specific scavenger receptors.
R. Abraham (1997)
10.1016/s0021-9258(18)53729-7
Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices.
Albert M. Pearson (1993)
10.1006/BBRC.2000.2216
Selective activation of antitumor activity of macrophages by the delivery of muramyl dipeptide using a novel polynucleotide-based carrier recognized by scavenger receptors.
S. Srividya (2000)
10.1002/JPS.2600721003
Physiologically based pharmacokinetic modeling: principles and applications.
L. E. Gerlowski (1983)
10.1055/S-2007-1007100
Hepatocyte-directed gene delivery by receptor-mediated endocytosis.
R. M. Smith (1999)
10.1016/S0168-3659(97)00236-8
Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells.
S. Wang (1998)
10.1248/BPB.17.296
Manipulation of renal disposition of human recombinant superoxide dismutase by chemical modification.
K. Mihara (1994)
10.1016/0006-2952(93)90273-Y
Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules.
E. Franssen (1993)
Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages.
R. Abraham (1995)
10.1016/0014-5793(94)80511-3
Enhanced intracellular delivery of doxorubicin by scavenger receptor‐mediated endocytosis for preferential killing of histiocytic lymphoma cells in culture
S. Basu (1994)
10.1006/BBRC.1998.8400
Maleylated-BSA enhances production of nitric oxide from macrophages.
P. Alford (1998)
10.1016/0020-708X(82)90144-2
The preparation and labeling of DTPA-coupled albumin.
D. Hnatowich (1982)
Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins.
J. Duncan (1993)
10.1016/S0378-5173(97)04899-0
Pharmacokinetic analysis of scavenger receptor-mediated uptake of anionized proteins in the isolated perfused rat liver
H. Furitsu (1997)
Modulation of T cell cytokine profiles and peptide-MHC complex availability in vivo by delivery to scavenger receptors via antigen maleylation.
N. Singh (1998)
10.1016/0968-0004(92)90322-Z
Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor.
M. Krieger (1992)
10.1016/0014-5793(95)01250-6
Circumvention of multidrug resistance in neoplastic cells through scavenger receptor mediated drug delivery
A. Mukhopadhyay (1995)
10.1073/PNAS.96.5.2285
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides.
K. Suzuki (1999)
MHC class I-restricted presentation of maleylated protein binding to scavenger receptors.
P. Bansal (1999)
10.1016/S0166-3542(96)01005-4
Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice.
M. Kuipers (1997)
Selective targeting and photodynamic destruction of intimal hyperplasia by scavenger-receptor mediated protein-chlorin e6 conjugates.
T. Nagae (1998)
10.1016/S0272-6386(97)90476-5
Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease.
J. Stockand (1997)
10.1016/S1286-4579(00)00297-5
The role of scavenger receptors in the innate immune system.
P. Gough (2000)
10.1023/A:1018972603494
Pharmacokinetic Analysis and Cellular Distribution of the Anti-HIV Compound Succinylated Human Serum Albumin (Suc-HSA) in Vivo and in the Isolated Perfused Rat Liver
R. W. Jansen (2004)
10.1016/s0021-9258(18)53971-5
Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors.
T. Doi (1993)
10.1111/J.1768-322X.1984.TB00298.X
Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting
M. Monsigny (1984)
10.1042/BJ2840237
Scavenger-receptor-mediated delivery of daunomycin elicits selective toxicity towards neoplastic cells of macrophage lineage.
A. Mukhopadhyay (1992)
10.1152/AJPGI.1995.268.5.G849
Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties.
M. Nishikawa (1995)
10.1152/AJPRENAL.1982.243.4.F379
Kinetics, competition, and selectivity of tubular absorption of proteins.
B. Sumpio (1982)
10.1016/0022-2836(87)90038-6
Interior and surface of monomeric proteins.
S. Miller (1987)



This paper is referenced by
10.1124/jpet.106.114959
S-Nitrosylation of Human Variant Albumin Liprizzi (R410C) Confers Potent Antibacterial and Cytoprotective Properties
Y. Ishima (2007)
10.1074/jbc.M807009200
S-Nitrosylated Human Serum Albumin-mediated Cytoprotective Activity Is Enhanced by Fatty Acid Binding*
Y. Ishima (2008)
10.1002/JPS.20147
Physicochemical, tissue distribution, and vasodilation characteristics of nitrosated serum albumin: delivery of nitric oxide in vivo.
H. Katsumi (2004)
10.1002/9780470571224.PSE538
Therapeutic Antibodies—Protein Engineering to Influence ADME, PK, and Efficacy
Tatsuhiko Tachibana (2015)
10.1021/bc2005363
S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects.
Y. Ishima (2012)
10.1021/acs.molpharmaceut.6b00557
Development of PEGylated Cysteine-Modified Lysine Dendrimers with Multiple Reduced Thiols To Prevent Hepatic Ischemia/Reperfusion Injury.
H. Katsumi (2016)
10.1517/17425247.3.3.355
Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes
M. Nishikawa (2006)
10.1371/journal.pone.0135966
Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo
H. Katsumi (2015)
10.1002/adhm.201200320
Extracellular matrix heterogeneity regulates three-dimensional morphologies of breast adenocarcinoma cell invasion.
Yoojin Shin (2013)
10.1111/j.1365-2567.2004.01871.x
Efficient scavenger receptor‐mediated uptake and cross‐presentation of negatively charged soluble antigens by dendritic cells
Kohsuke Shakushiro (2004)
10.2133/DMPK.18.230
Analysis of hepatic disposition of native and galactosylated polyethylenimine complexed with plasmid DNA in perfused rat liver.
S. Fumoto (2003)
10.1023/B:PHAM.0000016249.52831.a5
Uptake and Cytotoxicity of Chitosan Molecules and Nanoparticles: Effects of Molecular Weight and Degree of Deacetylation
M. Huang (2004)
10.1007/s11095-017-2243-y
Elucidation of the Mechanism of Increased Activity of Immunostimulatory DNA by the Formation of Polypod-like Structure
K. Mohri (2017)
10.1201/B12368-5
- Blood, Plasma, Cells, and Other Biological Fluids
R. Lundblad (2012)
10.3390/pharmaceutics12020132
Practical Guide for Quantification of In Vivo Degradation Rates for Therapeutic Proteins with Single-Cell Resolution Using Fluorescence Ratio Imaging
Ian Nessler (2020)
10.1196/annals.1333.083
Increased Protein Glycation in Cirrhosis and Therapeutic Strategies to Prevent It
N. Ahmed (2005)
10.1016/J.BBAPAP.2007.09.001
Changes of net charge and alpha-helical content affect the pharmacokinetic properties of human serum albumin.
Yasunori Iwao (2007)
10.1016/j.xphs.2018.06.022
Pharmacokinetics and Preventive Effects of Sulfo-Albumin as a Novel Macromolecular Hydrogen Sulfide Prodrug on Carbon Tetrachloride-Induced Hepatic Injury.
K. Sakai (2018)
10.1186/s12864-017-4336-8
Success: evolutionary and structural properties of amino acids prove effective for succinylation site prediction
Y. López (2017)
10.18419/opus-2165
Serum albumin and its interaction with the neonatal Fc receptor (FcRn) : characterization of the albumin/FcRn-binding mechanism
Aline Färber-Schwarz (2013)
10.1248/BPB.32.527
Pharmaceutically important pre- and posttranslational modifications on human serum albumin.
M. Otagiri (2009)
Title Pharmacokinetic considerations for targeted drug delivery
F. Yamashita (2016)
10.1124/dmd.114.060319
Evaluation of Near Infrared Fluorescent Labeling of Monoclonal Antibodies as a Tool for Tissue Distribution
Kip P. Conner (2014)
10.1016/J.IJPHARM.2007.09.030
Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
M. Nishikawa (2008)
10.1016/J.ADDR.2004.12.003
Theoretical considerations involving the pharmacokinetics of plasmid DNA.
M. Nishikawa (2005)
10.1016/J.JCONREL.2004.11.006
Cationic charge-dependent hepatic delivery of amidated serum albumin.
Shen-Feng Ma (2005)
10.1023/A:1022612422769
Monitoring the in Vivo Delivery of Proteins from Carbomer Hydrogels by X-Ray Fluorescence
Donald S. MacLean-McDavitt (2004)
10.1016/j.jconrel.2014.06.001
Glycosylation-mediated targeting of carriers.
S. Kawakami (2014)
10.1007/s11095-004-1880-0
Pharmacokinetic and Tissue Distribution Mechanism of Mouse Recombinant Heat Shock Protein 70 in Mice
Seiji Takemoto (2004)
A study of calcification-inducing succinylated type I atelocollagen
Han Hee Cho (2004)
10.1021/acs.molpharmaceut.6b01091
Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance
Cornelius Cilliers (2017)
10.1002/jpen.1451
Hypoalbuminemia: Pathogenesis and Clinical Significance
P. Soeters (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar